CLO25-072: A Multicenter, Randomized, Controlled, Non-Inferiority Study of Narlumosbart Compared With Denosumab in the Treatment of Bone Disease in Patients With Multiple Myeloma

Honghui Huang, Fei Li, Yan Xu, Wenming Chen, Guangxun Gao, Zhongjun Xia, Xiaobing Huang, Jun Luo, Xiaoling Guo, Chunrui Li, Chunyan Sun, Baijun Fang, Fengyan Jin, Yongqian Jia, Shuhao Mei, Juan Du, Rong Zhan, Zhen Cai, Luqun Wang, Hongming Huang, Hongfeng Ge, Xiuhua Han, Jian HouJournal of the National Comprehensive Cancer Network 2025 · DOI

Abstract

"CLO25-072: A Multicenter, Randomized, Controlled, Non-Inferiority Study of Narlumosbart Compared With Denosumab in the Treatment of Bone Disease in Patients With Multiple Myeloma" published on 28 Mar 2025 by National Comprehensive Cancer Network.
BibTeX
@article{huang2025clo,
  author = {Honghui Huang and Fei Li and Yan Xu and Wenming Chen and Guangxun Gao and Zhongjun Xia and Xiaobing Huang and Jun Luo and Xiaoling Guo and Chunrui Li and Chunyan Sun and Baijun Fang and Fengyan Jin and Yongqian Jia and Shuhao Mei and Juan Du and Rong Zhan and Zhen Cai and Luqun Wang and Hongming Huang and Hongfeng Ge and Xiuhua Han and Jian Hou},
  title = {{CLO25-072: A Multicenter, Randomized, Controlled, Non-Inferiority Study of Narlumosbart Compared With Denosumab in the Treatment of Bone Disease in Patients With Multiple Myeloma}},
  journal = {Journal of the National Comprehensive Cancer Network},
  year = {2025},
  doi = {10.6004/jnccn.2024.7215},
}

Loading related content...

Figure